Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Diacerein. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101104583A details a novel two-step oxidation route for diacerein, offering cost reduction in API manufacturing and enhanced supply chain reliability through chrome-free options.
Patent CN103360250A reveals a novel ZnCl2-catalyzed acetylation route for Diacerein, eliminating toxic chromium reagents and ensuring high purity for osteoarthritis drug manufacturing.
Novel chromium-free oxidation route for high-purity diacerein production ensuring cost efficiency and supply chain stability.